Trials / Not Yet Recruiting
Not Yet RecruitingNCT06190080
Outcome of Children With Eosinophilic Esophagitis
Outcomes of Children With Eosinophilic Esophagitis: a Prospective Monocentric Observational Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- Sponsor
- Fondation Lenval · Academic / Other
- Sex
- All
- Age
- 2 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The investigator would like to create a prospective cohort of patients in order to describe eosinophilic esophagitis with the specificities corresponding to our geographical territory, and to study their evolution at 3 months, 6 months, 12 months, 18 months and 24 months. This study would also enable us to investigate the quality of life of these chronically ill patients
Detailed description
The investigator would like to create a prospective cohort of 16 patients included over 2 years in order to determine the rate of complete remission (clinical, endoscopic and histological) at 3 months, 6 months, 12 months, 18 months and 24 months of treatment initiation. It is also planned to describe this cohort of pediatric EO patients at inclusion and throughout follow-up, and to study their quality of life. Follow-up visits is organized every 3 months with a gastropediatrician, who assesses the patient's symptoms (PEESS score) and quality of life (PedsQL eosinophilic esophagitis module and PedsQL 4.0 Generic Core Scales). If treatment needs to be introduced or changed, a digestive endoscopy with biopsies will be carried out at 3 months to determine whether the patient is in remission or not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Digestive endoscopy | Digestive endoscopies are performed in the operative room under general anaesthetic 3 months after the introduction or change of treatment. Biopsies of the upper, middle and lower thirds of the esophagus will be taken and analyzed for pathology. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2028-03-01
- Completion
- 2028-12-01
- First posted
- 2024-01-05
- Last updated
- 2024-01-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06190080. Inclusion in this directory is not an endorsement.